More on Integrated Device Technology (IDTI): FQ3 top line misses estimates as revenue declines 4% Y/Y on broad-based weakness in demand. Bottom line numbers met estimates, due in large part to reduced operating expenses and an improved product mix. The company lowers guidance going forward however, as near term visibility and demand appear limited. It now expects FQ4 sales in the range of $104M to $112M, below Street estimates of $120M. Shares -2.2% AH.